Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China · Delayed Price · Currency is CNY 14.68
-0.21 (-1.41%)
Aug 31, 2026, 3:00 PM CST
SHA:600535 Market Cap
SHA:600535 has a market cap or net worth of 21.93 billion as of August 31, 2026. Its market cap has decreased by -11.14% in one year.
Market Cap
21.93B
Enterprise Value
19.25B
Revenue
8.15B
Ranking
n/a
PE Ratio
17.92
Stock Price
14.68
ChartMarket Cap Chart
Since November 3, 2004, SHA:600535's market cap has increased from 3.65B to 21.93B, an increase of 501.18%. That is a compound annual growth rate of 8.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 21.93B | -2.59% |
| Dec 31, 2025 | 22.51B | 4.22% |
| Dec 31, 2024 | 21.60B | -15.04% |
| Dec 29, 2023 | 25.43B | 59.04% |
| Dec 30, 2022 | 15.99B | -32.76% |
| Dec 31, 2021 | 23.78B | 6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.19B |
| Apeloa Pharmaceutical Co.,Ltd | 24.01B |
| Hubei Jumpcan Pharmaceutical | 23.09B |
| Walvax Biotechnology | 22.84B |
| Harbin Pharmaceutical Group | 22.67B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.39B |
| Guangdong Zhongsheng Pharmaceutical | 21.97B |
| Jilin Aodong Pharmaceutical Group | 21.83B |